• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Fundamentals of CVD Risk Assessment: Guideline Topline for Primary Care


Assessment of CVD risk is the foundation of primary prevention and integral to primary care. Brush up on the fundamental tools of risk estimation from the ACC/AHA guidelines.


Assessment of atherosclerotic cardiovascular disease (ASCVD) risk, the foundation of primary prevention, is a critical guide for decision-making about potential interventions, including pharmacotherapy.

The American College of Cardiology (ACC)/American Heart Association (AHA) 2019 clinical practice guidelines emphasize the essential roles of clinician-patient discussions and a patient-centered approach to all treatment decisions whether the topic is lifestyle change or initiating medication.

In this Guideline Topline slide show, get a concise summary of the recommended tools for evaluating patient CVD risk, refining the risk, and for placing the patient at the center of therapeutic choice.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2023 MJH Life Sciences

All rights reserved.